US Patent 7282608 Inhibitors of histone deacetylase
Patent 7282608 was granted and assigned to MethylGene on October, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Daniel Delorme0
Frederic Gaudette0
Stephane Raeppel0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+402 characters)
Article
Patent abstract
The invention provides compoods and methods for treating cell proliferative-diseases. The invention provides new inhibitors of histone deacetylase enzymatic activity, compositions of the compounds comprising the inhibitors and a pharmaceutically acceptable carrier, excipient, or diluent, and methods of using the compounds to inhibit cellular proliferation in vitro and therapeutically.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07282608 Inhibitors of histone deacetylase US Patent 7282608 Inhibitors of histone deacetylase
Infobox
Patent Number
072826080
Patent Number
72826080
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072826080
Date of Patent
October 16, 2007
0Patent Application Number
105314060
Date Filed
October 16, 2003
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07282608 Inhibitors of histone deacetylase
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07282608
Date of patent
October 16, 2007
Patent application number
10531406
Date Filed
October 16, 2003
Patent primary examiner
Find more entities like US Patent 7282608 Inhibitors of histone deacetylase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
